Follow the people · Insider

JD

Joanne M. Donovan

Insider · Cmo · EWTX

Joanne M. Donovan files insider transactions with the SEC as a cmo of Edgewise Therapeutics (EWTX). We hold 7 disclosed purchases and sales filed since 30 June 2015, 2 of them in the last 90 days.

  • Files forEWTX
  • Disclosed buys and sells7 in all, 2 in the last 90 days
  • Last disclosure14 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 30 April 202113 August 2026Cmo · Edgewise Therapeutics (EWTX)54 Form 4 lines · source: SEC Form 4
  • Filed 30 June 201512 February 2020CMO; SVP Clinical Development · Catabasis Pharmaceuticals (CATB)10 Form 4 lines · source: SEC Form 4

Everything they disclosed

64 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.